2026 SCAI SHOCK

Jennifer A Rymer, MD, MBA, MHS

Jennifer A Rymer, MD, MBA, MHS
Duke University Hospital
Chapel Hill, NC
USA

Papers:

Breakfast Session: Incorporating Hemodynamic Profiling, Phenotyping and Staging into Care Across the CS Spectrum
Lunch Program: Optimizing Antiplatelet Therapy in Cardiogenic Shock
Breakout Session A: Care Models in the Management of MCS
Introductory Remarks
Evidence for Use of Cangrelor in Cardiogenic Shock from Observational Data: Where are we in 2026?
Intracoronary Imaging & Physiology – Does It Matter in Shock PCI?